Lofexidine Tablet
Product Images NDC 70954-909

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lofexidine (NDC 70954-909). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-1 (Container 1)

Label-1 (Container 1)
This is a description for a medication called Lofexidine in tablet form. The tablets should be stored in the original container, protected from heat and moisture, with the bottle tightly closed. Each tablet contains 0.18 mg of Lofexidine. The storage temperature is between 20°C to 25°C (68°F to 77°F). It is important to keep this medication out of reach of children. The medication is distributed by ANI Pharmaceuticals, Inc. with an expiration date indicated. Please refer to the package insert for full prescribing information.*
FDA Label Image

Label-2 (Container 2)

Label-2 (Container 2)
This is a description of Lofexidine tablets with dosage information, storage instructions, and safety precautions. The tablets contain Lofexidine 0.18 mg (equivalent to 0.2 mg lofexidine hydrochloride). It is advised to store and dispense the tablets in the original container, protect them from heat and moisture, and keep the bottle tightly closed. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). The medication should be kept away from children and the package insert should be consulted for full prescribing information. The tablets are distributed by ANI Pharmaceuticals, Inc. with an indicated expiration date (YYYY/MMM) and serial number for reference.*
FDA Label Image

Graph4 (Graphfour)

FDA Label Image

Graphone (Graphone)

Graphone (Graphone)
This text provides information about a study involving the use of the drug Loforidine, Lofexidine 2 88mg, and a placebo on a specific study day. It seems to be part of a research or clinical trial document.*
FDA Label Image

Graph-3 (Graphthree)

Graph-3 (Graphthree)
This text appears to mention a medication called Lofexidine with a specific dosage of 2.88 mg. It may be related to a study or clinical trial, as it also includes headings like "Study Day".*
FDA Label Image

Graph2 (Graphtwo)

FDA Label Image

Image-1 (Image 1)

Image-1 (Image 1)
This text describes symptoms related to low blood pressure, such as lightheadedness, slow heartbeat, feeling faint at rest or when standing up, and dizziness. These symptoms may indicate a decrease in blood pressure level and should be evaluated by a healthcare professional.*
FDA Label Image

Image-2 (Image 2)

Image-2 (Image 2)
This text lists symptoms that may be associated with low blood pressure, including dizziness, lightheadedness, slow heart rate, sleepiness, and dry mouth. These symptoms can serve as indicators of low blood pressure and should prompt further evaluation by a medical professional.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.